SEC Form D private-offering filing

Illexcor Therapeutics, Inc.

Name: Illexcor Therapeutics, Inc. - new SEC Form D private-offering filing, Henrico, VA
Published: 2026-05-08

A new SEC Form D private-offering notice from Henrico, VA, a $69,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Illexcor Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing oral small molecule therapies for sickle cell disease, including lead candidate ILX002.

Filed 2026-05-08Filed to raise $69,000,000First money in 2026-04-15Raised so far $13,000,000HQ (as filed) Henrico, VASector Biotech ✓Stage (inferred) GrowthCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified illexcor.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Virginia →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.